Syon Capital’s Bio-Techne TECH Stock Holding History

Syon Capital’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,674	Closed	-$401K	–	1003
2026 Q1	$401K	Sell	7,674 -3,400	-31%	-$204K	0.02%	639
2025 Q4	$651K	Sell	11,074 -1,039	-9%	-$63.1K	0.03%	462
2025 Q3	$674K	Buy	12,113 +6,888	+132%	+$369K	0.04%	384
2025 Q2	$269K	Buy	+5,225	New	+$263K	0.02%	589

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Syon Capital's TECH Position: Q2 2026 in Review

Syon Capital sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 7,674 shares — an estimated $401K sold.

Syon Capital first reported a position in TECH in Q2 2025 and held it in 4 quarters. The position peaked at $674K in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Syon Capital reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
Syon Capital sold 7,674 Bio-Techne shares in Q2 2026, an estimated $401K.
Syon Capital first reported a position in Bio-Techne in Q2 2025 and held it in 4 quarters.
Syon Capital's Bio-Techne position peaked at $674K in Q3 2025.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.